Status:

COMPLETED

Glucocorticoids in COVID-19 (CORTIVID)

Lead Sponsor:

Fundacion Miguel Servet

Collaborating Sponsors:

Complejo Hospitalario de Navarra

Hospital Sant Joan Despí Moisès Broggi

Conditions:

Covid-19 Pneumonia

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

Around 30% of admitted patients with COVID-19 pneumonia develop a hyper-inflammatory state whose progression to an acute respiratory distress syndrome (ARSD) could be prevented by the early initiation...

Eligibility Criteria

Inclusion

  • Age ≥18 years old.
  • Diagnosis of SARS-CoV-2 pneumonia confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) on nasopharyngeal swab or sputum according to the recommendations of the Spanish Ministry of Health.
  • Length of symptoms consistent with COVID-19 ≥7 days.
  • Hospital admission.
  • At least one of the following: CRP \>60 mg/L, IL-6 \>40 pg/mL, ferritin \>1000 μg/L.
  • Acceptation of informed consent

Exclusion

  • Allergy or contraindication to any of the drugs under study.
  • SpO2 \<90% (in air ambient) or PaO2 \<60 mmHg (in ambient air) or PaO2/FiO2 \<300 mmHg.
  • Ongoing treatment with glucocorticoids, immunosuppressive, or biologic drugs with another indication.
  • Decompensated diabetes mellitus.
  • Uncontrolled hypertension.
  • Psychotic or manic disorder.
  • Active cancer.
  • Pregnancy or lactation.
  • Clinical or biochemical suspicion (procalcitonin \>0.5 ng/mL) of active infection other than SARS-CoV-2.
  • Out-of-hospital management patient.
  • Conservative or palliative management patient.
  • Participation in another clinical trial.
  • Any important and uncontrolled medical, psychological, psychiatric, geographic or social problem that contraindicates the patient's participation in the trial or that does not allow adequate follow-up and adherence to the protocol and evaluation of the study results.

Key Trial Info

Start Date :

May 15 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 9 2021

Estimated Enrollment :

72 Patients enrolled

Trial Details

Trial ID

NCT04438980

Start Date

May 15 2020

End Date

April 9 2021

Last Update

May 17 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Hospital Sant Joan Despí Moisès Broggi

Sant Joan Despí, Barcelona, Spain

2

Complejo Hospitalario de Navarra

Pamplona, Navarre, Spain, 31008